carbidopa has been researched along with Cardiac Failure in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Adamski, P; Anielska-Michalak, E; Bartuś, S; Brycht, O; Budaj, A; Curzytek, A; Drożdż, J; Dudek, A; Gąsior, M; Gromadziński, L; Gruchała, M; Grzelakowska, K; Grzelakowski, P; Jaguszewski, M; Jankowski, P; Kamiński, L; Kasprzak, M; Kaźmierczak, J; Kleinrok, A; Kostkiewicz, M; Koziński, M; Król, P; Kryś, J; Kubica, A; Kubica, J; Kulawik, T; Legutko, J; Lesiak, M; Leszek, P; Minczew, G; Mindykowski, M; Mitkowski, P; Navarese, EP; Nessler, J; Ostrowska, M; Pawlak, A; Podhajski, P; Prokopczuk, J; Skonieczny, G; Sobkowicz, B; Sowiński, S; Stankala, S; Stolarek, W; Szymański, P; Tomaszuk-Kazberuk, A; Tycińska, A; Wester, A; Wilczewski, P; Zdrojewski, T | 1 |
1 other study(ies) available for carbidopa and Cardiac Failure
Article | Year |
---|---|
Impact of COVID-19 pandemic on acute heart failure admissions and mortality: a multicentre study (COV-HF-SIRIO 6 study).
Topics: Acute Disease; Carbidopa; COVID-19; Drug Combinations; Heart Failure; Humans; Levodopa; Pandemics; Retrospective Studies; SARS-CoV-2 | 2022 |